Purchase Order 75N91018P00488

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $133,380.00 on September 28, 2017, with an ultimate completion date of November 16, 2017. The order is firm fixed-price with no small business set-aside. Performance takes place in Santa Clara, California. The source does not specify the laser systems or equipment being purchased.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $8,800.00 on January 18, 2018, with completion scheduled for February 11, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. on December 18, 2017, with a ceiling value of $5,566.05 and an ultimate completion date of December 28, 2018. The order is firm fixed price with no set-aside. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $19,190 on July 25, 2018, for a maintenance agreement on a Coherent laser group system. Performance is located in Santa Clara, California, with an ultimate completion date of July 24, 2019. The order is firm fixed-price; no set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $19,669.50 on July 23, 2019. The service agreement, priced on a firm fixed-price basis, calls for ultimate completion by July 24, 2020. Work is performed in Bethesda, Maryland. The source does not specify the nature of the goods or services procured.</p>

The National Cancer Institute issued a purchase order to Coherent Inc. on June 30, 2021, valued at $14,751.77, for maintenance agreement services with an ultimate completion date of July 24, 2022. The order represents a firm fixed-price acquisition to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of fund availability. Performance occurs in Bethesda, Maryland. No small business...

<p>The National Cancer Institute awarded a purchase order to Coherent NA, Inc. for $34,674.50 on August 5, 2026 to procure an OBIS 304NM XT 40MW laser system, with an ultimate completion date of August 4, 2027. Performance occurs in Bethesda, Maryland. The order references quote COHR-395680-1 and carries firm fixed-price terms on a full-and-open, no-set-aside basis for specialized laser instrumentation.</p>

The National Institute of Neurological Disorders and Stroke awarded a purchase order to Coherent Inc. valued at $22,800.00 on May 31, 2018. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Ultimate completion is May 31, 2018. The Productivity Plus Service Agreement–Gold procurement was structured as a full-and-open commercial item acquisition. Coherent manufactures laser systems and related equipment for federal research...

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $21,636 firm fixed price purchase order to Coherent NA, Inc. for a service agreement covering the Chameleon Vision II and Chameleon MPX X laser system. Coherent NA, Inc. is a subsidiary of Coherent Inc. and will perform the work at its Rockville, Maryland facility located at 20852. The period of performance is one year, running from July 25, 2023 through July 24, 2024. No additional...

This is a $250,758.00 firm fixed price purchase order awarded by the National Cancer Institute (an agency of the U.S. Department of Health and Human Services) to Coherent Inc., a global leader in materials, networking, and lasers. The contract is for the provision of a &quot;CHAMELEON SYSTEM: VISION II WITH AN MXP WAVELENGTH EXTENSION,&quot; a laser system. No set-aside designation was used. Coherent Inc. has a history of providing lasers, laser systems, and related components and maintenance...